AEs experienced during acalabrutinib treatment (≥15% any grade) for all treated patients (N = 33)
AE . | n (%) . | ||||
---|---|---|---|---|---|
Any grade . | Grade 1 . | Grade 2 . | Grade 3 . | Grade 4 . | |
Diarrhea | 19 (58) | 15 (45) | 4 (12) | 0 | 0 |
Headache | 13 (39) | 9 (27) | 4 (12) | 0 | 0 |
Cough | 11 (33) | 6 (18) | 5 (15) | 0 | 0 |
Weight increased | 10 (30) | 6 (18) | 3 (9) | 1 (3) | 0 |
Nausea | 9 (27) | 6 (18) | 2 (6) | 1 (3) | 0 |
Contusion | 8 (24) | 5 (15) | 3 (9) | 0 | 0 |
Upper respiratory tract infection | 8 (24) | 2 (6) | 5 (15) | 1 (3) | 0 |
Arthralgia | 7 (21) | 6 (18) | 1 (3) | 0 | 0 |
Pyrexia | 7 (21) | 5 (15) | 1 (3) | 1 (3) | 0 |
Vomiting | 7 (21) | 5 (15) | 2 (6) | 0 | 0 |
Fatigue | 6 (18) | 3 (9) | 3 (9) | 0 | 0 |
Myalgia | 6 (18) | 2 (6) | 3 (9) | 0 | 0 |
Rash | 6 (18) | 5 (15) | 1 (3) | 0 | 0 |
Constipation | 5 (15) | 4 (12) | 1 (3) | 0 | 0 |
Dizziness | 5 (15) | 3 (9) | 2 (6) | 0 | 0 |
Ecchymosis | 5 (15) | 4 (12) | 1 (3) | 0 | 0 |
Fall | 5 (15) | 3 (9) | 2 (6) | 0 | 0 |
Noncardiac chest pain | 5 (15) | 3 (9) | 1 (3) | 1 (3) | 0 |
AE . | n (%) . | ||||
---|---|---|---|---|---|
Any grade . | Grade 1 . | Grade 2 . | Grade 3 . | Grade 4 . | |
Diarrhea | 19 (58) | 15 (45) | 4 (12) | 0 | 0 |
Headache | 13 (39) | 9 (27) | 4 (12) | 0 | 0 |
Cough | 11 (33) | 6 (18) | 5 (15) | 0 | 0 |
Weight increased | 10 (30) | 6 (18) | 3 (9) | 1 (3) | 0 |
Nausea | 9 (27) | 6 (18) | 2 (6) | 1 (3) | 0 |
Contusion | 8 (24) | 5 (15) | 3 (9) | 0 | 0 |
Upper respiratory tract infection | 8 (24) | 2 (6) | 5 (15) | 1 (3) | 0 |
Arthralgia | 7 (21) | 6 (18) | 1 (3) | 0 | 0 |
Pyrexia | 7 (21) | 5 (15) | 1 (3) | 1 (3) | 0 |
Vomiting | 7 (21) | 5 (15) | 2 (6) | 0 | 0 |
Fatigue | 6 (18) | 3 (9) | 3 (9) | 0 | 0 |
Myalgia | 6 (18) | 2 (6) | 3 (9) | 0 | 0 |
Rash | 6 (18) | 5 (15) | 1 (3) | 0 | 0 |
Constipation | 5 (15) | 4 (12) | 1 (3) | 0 | 0 |
Dizziness | 5 (15) | 3 (9) | 2 (6) | 0 | 0 |
Ecchymosis | 5 (15) | 4 (12) | 1 (3) | 0 | 0 |
Fall | 5 (15) | 3 (9) | 2 (6) | 0 | 0 |
Noncardiac chest pain | 5 (15) | 3 (9) | 1 (3) | 1 (3) | 0 |